Inozyme Pharma Inc (INZY)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.39M | -16.91M | -19.53M | -18.37M | -16.39M | -18.07M | -22.81M | -24.35M |
| Pre Tax Income | -15.26M | -16.37M | -18.54M | -17.4M | -15.58M | -16.64M | -21.54M | -23.35M |
| Net Income | -15.26M | -16.37M | -18.54M | -17.4M | -15.58M | -16.64M | -21.54M | -23.35M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -15.58M | -17.11M | -19.36M | -18.4M | -16.42M | -18.05M | -22.79M | -24.4M |
| EBITDA | -15.21M | -16.72M | -19.34M | -18.16M | -16.19M | -17.87M | -22.6M | -24.16M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.59M | -20.81M | -57.04M | -56.65M | -68.68M | -75.65M |
| Pre Tax Income | -6.96M | -19.72M | -56.42M | -56.62M | -67.06M | -71.17M |
| Net Income | -6.96M | -19.72M | -56.42M | -56.62M | -67.06M | -71.17M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
| EBIT | -7.25M | -20.83M | -57.04M | -56.84M | -68.99M | -75.67M |
| EBITDA | -11.57M | -20.72M | -56.82M | -55.97M | -67.93M | -74.81M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
